Snapshot from Aug 25, 2026 at 07:00 UTC. For live data and tracking: View Live

United Kingdom & AstraZeneca

13 shared events · Importance 5 · Last updated Aug 24, 2026

Importance
5
Shared Events
13
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
84
Domestic
United Kingdom: The UK government expanded its Global Talent visa to over 100 research-intensive businesses, aiming to attract top international researchers and support economic growth.
AstraZeneca: As a major pharmaceutical company, AstraZeneca can now sponsor researchers through the Global Talent visa, potentially enhancing its R&D capabilities.
Aug 05, 2026 · 6 articles
77
Business
United Kingdom: The UK could lose a national champion if AstraZeneca's ties weaken, raising concerns about the London market's attractiveness and potential job losses.
AstraZeneca: AstraZeneca is the initiator of the merger talks, seeking to expand its US presence. Its shares fell over 7% on the news, reflecting investor skepticism about the deal's value and execution risk.
Aug 02, 2026 · 60 articles
35
Tech
United Kingdom: The United Kingdom is providing up to £20 million to contain the Ebola outbreak in the Democratic Republic of the Congo and Uganda, supporting international efforts and frontline health workers.
AstraZeneca: AstraZeneca is mentioned in the context of the University of Oxford's vaccine technology, which is similar to their COVID-19 vaccine.
May 22, 2026 · 36 articles
35
Accidents
United Kingdom: Approved human trials for the Oxford vaccine, contributing to global vaccine development.
AstraZeneca: Technology from its COVID-19 vaccine is used in the Oxford Ebola vaccine, indirectly involved.
Aug 01, 2026 · 301 articles
32
Business
United Kingdom: The United Kingdom is the home country of AstraZeneca, and the event is relevant to the UK pharmaceutical sector and stock market.
AstraZeneca: AstraZeneca is the central company, facing another pipeline setback with the discontinuation of the volrustomig trial. Despite this, it reported positive results from other trials and reaffirmed its 2030 revenue target, with shares rising slightly.
Aug 17, 2026 · 20 articles
24
Business
United Kingdom: New PM Andy Burnham's fiscal policy comments spooked investors.
AstraZeneca: Investors punished the stock over merger talks with Bristol Myers Squibb.
Jul 14, 2026 · 280 articles
24
Accidents
United Kingdom: Hosting Oxford vaccine trial. Its regulatory environment supports research.
AstraZeneca: Its COVID-19 vaccine technology is used in the Oxford candidate, but AstraZeneca itself is not directly involved in the Ebola response.
Mar 09, 2018 · 543 articles
17
Accidents
United Kingdom: The United Kingdom>>> is one of multiple nations that have implemented travel restrictions in response to the Ebola outbreak, indicating a global concern.
AstraZeneca: AstraZeneca was involved in the development of the COVID-19 vaccine platform that is now being considered for a Bundibugyo ebolavirus vaccine, showcasing its role in vaccine innovation.
May 18, 2026 · 505 articles
14
Domestic
United Kingdom: The UK previously narrowed its COVID-19 vaccination programme to older adults, care home residents, and immunocompromised individuals.
AstraZeneca: AstraZeneca's vaccine was previously suspended for under 60s in Germany in 2021 due to blood clot concerns; not directly affected by current policy.
Jul 13, 2026 · 6 articles
14
Business
United Kingdom: The United Kingdom hosts the new co-innovation hub in London, potentially boosting its position as a center for AI and life sciences.
AstraZeneca: AstraZeneca is mentioned as an existing AWS customer, but this event does not directly impact it.
Aug 10, 2026 · 7 articles
10
International
United Kingdom: UK stocks rose; pound strengthened.
AstraZeneca: AstraZeneca gained 1.3% after topping Q2 profit expectations.
Jul 08, 2026 · 472 articles
0
International
AstraZeneca: AstraZeneca announced a significant investment of $15 billion in China through 2030 to expand its medicines manufacturing and research, demonstrating confidence in the Chinese market.
Jan 30, 2026 · 9 articles
0
International
AstraZeneca: AstraZeneca's CEO, Pascal Soriot, is part of the business delegation, suggesting potential for increased pharmaceutical and healthcare sector cooperation with China.
Jan 27, 2026 · 34 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how United Kingdom and AstraZeneca interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.